open access

Vol 4 (2019): Continuous Publishing
CASE REPORTS
Published online: 2019-07-31
Get Citation

Retinoma — the first identified case in Jordan

Rashed Mustafa Nazzal, Yacoub Yousef, Katarzyna Nowomiejska, Robert Rejdak
DOI: 10.5603/OJ.2019.0007
·
Ophthalmol J 2019;4:52-55.

open access

Vol 4 (2019): Continuous Publishing
CASE REPORTS
Published online: 2019-07-31

Abstract

Retinoma (or retinocytoma) is a rare benign intraocular tumor with characteristic features and can be diagnosed clinically. In this article, we present a case report and a review of literature about retinoma. The case is about an incidentally diagnosed retinoma in an asymptomatic young female who presented for vision checkup and was found to have an intraocular translucent-grey, elevated mass extending into the vitreous cavity from the retina with the characteristic features of retinoma. The main differential diagnosis included retinoblastoma and astrocytic hamartoma. The mass showed no growth over a period of 6 months of follow up with colored fundus photography and ultrasound. This case is, to the best of our knowledge, the first case of retinoma diagnosed in Jordan.

Abstract

Retinoma (or retinocytoma) is a rare benign intraocular tumor with characteristic features and can be diagnosed clinically. In this article, we present a case report and a review of literature about retinoma. The case is about an incidentally diagnosed retinoma in an asymptomatic young female who presented for vision checkup and was found to have an intraocular translucent-grey, elevated mass extending into the vitreous cavity from the retina with the characteristic features of retinoma. The main differential diagnosis included retinoblastoma and astrocytic hamartoma. The mass showed no growth over a period of 6 months of follow up with colored fundus photography and ultrasound. This case is, to the best of our knowledge, the first case of retinoma diagnosed in Jordan.

Get Citation

Keywords

retinoma; retinocytoma; retinoblastoma; Jordan

About this article
Title

Retinoma — the first identified case in Jordan

Journal

Ophthalmology Journal

Issue

Vol 4 (2019): Continuous Publishing

Pages

52-55

Published online

2019-07-31

DOI

10.5603/OJ.2019.0007

Bibliographic record

Ophthalmol J 2019;4:52-55.

Keywords

retinoma
retinocytoma
retinoblastoma
Jordan

Authors

Rashed Mustafa Nazzal
Yacoub Yousef
Katarzyna Nowomiejska
Robert Rejdak

References (16)
  1. Gallie BL, Ellsworth RM, Abramson DH, et al. Retinoma: spontaneous regression of retinoblastoma or benign manifestation of the mutation? Br J Cancer. 1982; 45(4): 513–521.
  2. Sampieri K, Mencarelli MA, Epistolato MC, et al. Genomic differences between retinoma and retinoblastoma. Acta Oncol. 2008; 47(8): 1483–1492.
  3. Eagle RC, Shields JA, Donoso L, et al. Malignant transformation of spontaneously regressed retinoblastoma, retinoma/retinocytoma variant. Ophthalmology. 1989; 96(9): 1389–1395.
  4. Margo C, Hidayat A, Kopelman J, et al. Retinocytoma. A benign variant of retinoblastoma. Arch Ophthalmol. 1983; 101(10): 1519–1531.
  5. Balmer A, Munier F, Gailloud C. Retinoma. Case studies. Ophthalmic Paediatr Genet. 1991; 12(3): 131–137.
  6. Singh AD, Santos CM, Shields CL, et al. Observations on 17 patients with retinocytoma. Arch Ophthalmol. 2000; 118(2): 199–205.
  7. Dimaras H, Khetan V, Halliday W, et al. Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma. Hum Mol Genet. 2008; 17(10): 1363–1372.
  8. Lommatzsch PK, Zimmermann W, Lommatzsch R. [Spontaneous growth inhibition in retinoblastoma]. Klin Monbl Augenheilkd. 1993; 202(3): 218–223.
  9. Hadjistilianou T, De Francesco S, Martone G, et al. Retinocytoma associated with calcified vitreous deposits. Eur J Ophthalmol. 2006; 16(2): 349–351.
  10. Abouzeid H, Balmer A, Moulin AP, et al. Phenotypic variability of retinocytomas: preregression and postregression growth patterns. Br J Ophthalmol. 2012; 96(6): 884–889.
  11. Shah PK, Narendran V, Manayath GJ, et al. Atypical retinocytoma with diffuse vitreous seeds: An insight. Oman J Ophthalmol. 2011; 4(2): 81–83.
  12. Yousef YA, Nazzal RM, Khalil MB, et al. Management outcome(s) in eyes with retinoblastoma previously inadequately treated with systemic chemotherapy alone without focal therapy. Oman J Ophthalmol. 2017; 10(2): 70–75.
  13. Yousef Y, Mahameed I. External Beam Radiation Therapy for Retinoblastoma Resistant to Chemotherapy and Focal Treatment: Outcome and Predictive Factors. J Clin Exp Oncol. 2015; 04(02): 2–6.
  14. Abramson DH. Retinoma, retinocytoma, and the retinoblastoma gene. Arch Ophthalmol. 1983; 101(10): 1517–1518.
  15. Gallie BL, Dunn JM, Chan HS, et al. The genetics of retinoblastoma. Relevance to the patient. Pediatr Clin North Am. 1991; 38(2): 299–315.
  16. Jaradat I, Yousef YA, Mehyar M, et al. Retinoblastoma in Jordan: an epidemiological study (2006-2010). Hematol Oncol Stem Cell Ther. 2011; 4(3): 126–131.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

VM Media sp. z o.o. VM Group sp.k., Grupa Via Medica, 73 Świętokrzyska St., 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl